Doctor Giuditta Benincasa

Doctor Giuditta Benincasa

University of Campania Luigi Vanvitell, Naples (Italy)

Member of:

Giuditta Benincasa is a Molecular Biologist and got her PhD in Translational Medicine at the Department of Advanced Medical and Surgical Sciences (DAMSS) of University of Campania "Luigi Vanvitelli" in Naples (Italy). During her two-year post-doc fellowship, she focused on epigenetic-sensitive mechanisms underlying heart failure with preserved ejection fraction with the support of Network Medicine approaches. The goal was to identify novel biomarkers useful to advance precision medicine and personalized therapy of heart failure and its differential clinical phenotypes.

Presentations Articles

DNA methylation profiling of circulating CD4+ T cells and network analysis reveal that JUNB, SETD7, and MEF2D genes predict patients with heart failure preserved vs. reduced ejection fraction

Event: ESC Congress 2023

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Young Investigator Awards Session in Heart Failure

Access

Circulating CD4+T/Methylation Signatures of Network-oriented SOCS3, ITGAL, NFIC, NCOR2, PGK1 Genes Associate with Hemodynamics in Pulmonary Arterial Hypertension Patients

Event: ESC Congress 2021 - The Digital Experience

Topic: Pulmonary Hypertension

Session: Pulmonary circulation, pulmonary embolism, right heart failure e-posters

Access

Steatosis in explanted heart of type 2 diabetic patients with end-stage heart failure: progression of intra-myocytes fat accumulation in non-diabetic heart implanted in diabetic patients

Event: ESC Congress 2019

Topic: Comorbidities

Session: Cardiometabolic

Access

Effect of sacubitril-valsartan in reducing physical frailty in patients with advanced heart failure in waiting list for heart transplantation

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Treatment of the chronic heart failure

Access

Doctor Giuditta Benincasa

Biography

Contributor content

DNA methylation profiling of circulating CD4+ T cells and network analysis reveal that JUNB, SETD7, and MEF2D genes predict patients with heart failure preserved vs. reduced ejection fraction

Circulating CD4+T/Methylation Signatures of Network-oriented SOCS3, ITGAL, NFIC, NCOR2, PGK1 Genes Associate with Hemodynamics in Pulmonary Arterial Hypertension Patients

Steatosis in explanted heart of type 2 diabetic patients with end-stage heart failure: progression of intra-myocytes fat accumulation in non-diabetic heart implanted in diabetic patients

Effect of sacubitril-valsartan in reducing physical frailty in patients with advanced heart failure in waiting list for heart transplantation

ESC 365 is supported by